2型糖尿病患者合并肺癌的临床分析  

The clinical analysis of 60 cases of type 2 diabetic patients with lung cancer

作　　者：姜虹[1] 闫春良[2] 

机构地区：[1]北京市第六医院内科,北京100007 [2]北京航天总医院呼吸科,北京100076

出　　处：《中国肿瘤临床与康复》2013年第8期819-821,共3页Chinese Journal of Clinical Oncology and Rehabilitation

摘　　要：目的探讨糖尿病合并肺癌的临床特点。方法回顾性分析2008年12月至2012年7月收治的60例糖尿病合并肺癌患者的临床资料。结果糖尿病合并肺癌患者占同期糖尿病住院患者的28.8%;肺癌确诊时间在糖尿病之后、同时及之前的发生率分别为80.0%、11.7%和8.3%;糖尿病合并肺癌的病理类型50.0%为腺癌;33.3%为鳞癌。结论在临床上,糖尿病患者合并肺癌的发生率比较高,应该给予高度重视;此外,尽早有规律的控制血糖是取得良好预后的关键。Objective To investigate the clinical features of diabetes combined with lung cancer through research and analysis.Methods The clinical data of 60 cases diabetes combined with lung cancer of 208 cases of diabetic patients in our hospital from December 2008 to July 2012 were analyzed retrospectively.Results Diabetes combined with lung cancer accounted for 28.80% of the diabetic patients for the same period;Lung cancer was diagnosed before,while and after diabetes,the occurrence rate are 80.0%,11.7%,8.3%;In the pathological type of diabetes combined with lung cancer,50.0% are adenocarcinoma and 33.3% are squamous carcinoma.Conclusions In the clinical,the incidence of diabetes combined with lung cancer is relatively high,and should be highly valued;blood sugar control is the key to achieve good prognosis.

关 键 词：肺癌 糖尿病 临床特点 

分 类 号：R734.2[医药卫生—肿瘤]